Trial Profile
A Multicenter, Prospective Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Patient With Essential Hypertension
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2021
Price :
$35
*
At a glance
- Drugs Lercanidipine/valsartan (Primary) ; Amlodipine/valsartan
- Indications Essential hypertension
- Focus Adverse reactions
- Sponsors LG Chem; LG Life Sciences
- 20 Apr 2016 New trial record